Stay updated on Mazindol CR in Adults with ADHD Clinical Trial
Sign up to get notified when there's something new on the Mazindol CR in Adults with ADHD Clinical Trial page.

Latest updates to the Mazindol CR in Adults with ADHD Clinical Trial page
- Check7 days agoChange DetectedThe study record for the completed Phase 2 trial of controlled-release mazindol in adults with ADHD is displayed, including its design, eligibility criteria, locations, and outcome measures. No results are posted.SummaryDifference43%

- Check14 days agoChange DetectedThe footer revision identifier was updated from v3.7.2 to v3.8.0. The page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check21 days agoChange DetectedA notice was added above the page announcing NIH website transition updates and stating that federal agencies are using “Super Intelligence” instead of “Artificial Intelligence” during the transition.SummaryDifference1%

- Check28 days agoChange DetectedThe footer site revision identifier changed from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check35 days agoChange DetectedThe footer revision identifier changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check55 days agoChange DetectedAn error page displaying 403 Forbidden is now shown when loading the study record. The page includes a minimal HTML structure, a 403 title, and a Home link, replacing the expected study details.SummaryDifference17%

Stay in the know with updates to Mazindol CR in Adults with ADHD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Mazindol CR in Adults with ADHD Clinical Trial page.